Journal Logo

Articles by A. Falanga

ANTICOAGULANT THERAPY IN THROMBOCYTOPENIC PATIENTS WITH BLOOD CANCER AND CATHETER-RELATED VTE: RESULTS FROM A DELPHI CONSENSUS ON PLATELETS COUNT BELOW 50 X 109L: PF802

Napolitano, M.; avvisati, G.; Carpenedo, M.; More

HemaSphere. 3:353-354, June 2019.

THE COMBINATION OF LOW ADAMTS-13 ACTIVITY AND HIGH ANTI-ADAMTS13 ANTIBODIES AT REMISSION HIGHLY PREDICTS DISEASE RELAPSE IN PATIENTS WITH ACQUIRED TTP: A MULTI-INSTITUTIONAL STUDY: S1646

Schieppati, F.; Russo, L.; Marchetti, M.; More

HemaSphere. 3:761-762, June 2019.